86245-87-6

Basic information

• Product Name: Phenol, 2,2'-(1-phenyl-1H-1,2,4-triazole-3,5-diyl)bis-
• CAS NO: 86245-87-6
• Molecular Formula: C20H15N3O2
• Molecular Weight: 329.358
• Mol File: 86245-87-6.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Phenol, 2,2'-(1-phenyl-1H-1,2,4-triazole-3,5-diyl)bis-(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 2,2'-(1-phenyl-1H-1,2,4-triazole-3,5-diyl)bis-(86245-87-6)
• EPA Substance Registry System: Phenol, 2,2'-(1-phenyl-1H-1,2,4-triazole-3,5-diyl)bis-(86245-87-6)

Safety Data

• Hazardous Substances Data: 86245-87-6(Hazardous Substances Data)

Upstream product

• 69-72-7 salicylic acid 
• 1972-71-0 2-hydroxy-N-(2-hydroxybenzoyl)benzamide 
• 59-88-1 phenylhydrazine hydrochloride 
• 1218-69-5 2-(2-hydroxyphenyl)-4H-benzo[e][1,3]oxazin-4-one 
• 86245-83-2 2-(o-hydroxyphenyl)-4-oxo-1,3-benzoxazinium perchlorate 
• 100-63-0 phenylhydrazine 

Downstream Products

• 110981-90-3 Ni⁽²⁺⁾*C₂N₃(C₆H₅)(C₆H₄O)2^(2-)=Ni(C₂N₃(C₆H₅)(C₆H₄O)2) 
• 110981-89-0 [(3,5-bis(2-oxyphenyl)-1-phenyl-1,2,4-triazole)copper(II)] 
• 110981-91-4 Co⁽²⁺⁾*C₂N₃(C₆H₅)(C₆H₄O)2^(2-)=Co(C₂N₃(C₆H₅)(C₆H₄O)2) 
• 1376268-49-3 3,5-bis(2-methoxyphenyl)-1-phenyl-1H-1,2,4-triazole 
• 86245-88-7 1-phenyl-3,5-bis(o-acetoxyphenyl)-1,2,4-triazole 

Relevant articles and documents

Tridentate Complexes of Palladium(II) and Platinum(II) Bearing bis-Aryloxide Triazole Ligands: A Joint Experimental and Theoretical Investigation

A novel class of palladium(II) and platinum(II) complexes bearing tridentate bis-aryloxide triazole ligands was prepared by using straightforward and high-yielding synthetic routes. The complexes were fully characterized and the molecular structures of four derivatives were unambigously determined by single-crystal X-ray diffractometric analyses. For the most promising luminescent PtII derivatives, further experimental investigations were carried out to characterize their photophysical features and to ascertain the nature of the emitting excited state by means of electronic absorption, steady-state, and time-resolved emission techniques in different conditions. In degassed fluid solution the complexes displayed broad and featureless photoluminescence with λem=522-585 nm, excited-state lifetime up to few microseconds and quantum yield (PLQY) up to 17 %, depending on the nature of both ancillary ligand and substituent on the tridentate ligand. Computational investigation using density functional theory and time-dependent DFT were performed to gain insight into the electronic processes responsible for optical transitions and structure-photoluminescence relationship. Jointly, experimental and theoretical characterization indicated that the radiative transition arises from an excited state with admixed triplet-manifold metal-to-ligand charge transfer and ligand-centered (3MLCT/3LC) character. We elucidated the modulation of the photophysical properties upon variation of substituents for this new family of complexes.

CELL ACTIVATABLE IRON CHELATORS

Provided herein are compounds of the formula (I): wherein the variables are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used for the treatment of diseases or disorders, such as

PREPARATION OF NOVEL DEFERASIROX ANALOGUES FOR ANTIMALARIAL ACTIVITY

The present invention relates to processes for the preparation of novel deferasirox analogues for antimalarial activity. The present invention further provides process for synthesis of novel deferasirox analogues.